ENDEAVOR HEALTH
LIVE

Serial Number

98009181

Owner

Edward-Elmhurst Healthcare

Attorney

Rosanne Yang

First Use Date

Apr 1, 2025

Filing Date

May 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ENDEAVOR HEALTH Trademark

Serial Number: 98009181 • Registration: 8423985

ENDEAVOR HEALTH is a trademark filed by Edward-Elmhurst Healthcare on May 23, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Edward-Elmhurst Healthcare (29 trademarks)

Naperville, IL 60540

Entity Type: 03

Trademark Details

Filing Date

May 23, 2023

Registration Date

September 1, 2026

First Use Anywhere

April 1, 2025

First Use in Commerce

April 1, 2025

Published for Opposition

November 25, 2025

Goods & Services

Medical and health care services offered in hospital, ambulatory and outpatient settings, namely, hospital services, medical clinic services, medical clinics, physician services, home health care and hospice services, immediate and urgent medical care services, medical testing services for diagnostic or treatment purposes, and nursing care services; provision of home healthcare services; hospital and healthcare services; managed health care services; medical services; medical clinics; medical counseling services; providing medical profile and medical record analysis and assessments for diagnostic purposes; genetic testing for medical purposes; providing medical information, consultancy, and advisory services; preparation and generation of reports for medical diagnostic testing services, namely, medical diagnostic testing, monitoring and reporting services; pharmacogenomics testing for diagnostic or treatment services; addiction treatment services in the field of substance abuse; psychiatric services; medical services in the field of surgery; diagnostic and therapeutic radiology services; organ transplant services, namely, medical services; conducting sleep studies for medical diagnostic and treatment purposes and healthcare services, namely, treatment of sleep disorders; medical care with respect to pain management treatment; providing an internet website portal in the field of medical and healthcare services

Providing access to databases that enable users to access patient diagnostic health information, medical reports, and educational information in the area of medicine

Genomic tests composed primarily of reagents for medical or clinical purposes; genomic tests for analyzing DNA information composed primarily of reagents for medical or clinical purposes; kits composed of reagents for use in genetic testing for medical or clinical purposes

Organizing and conducting support groups relating to health issues

Providing referrals in the field of physician services; retail pharmacy services

Educational services, namely, providing courses of instruction in the field of medicine and healthcare through a medical school and providing continuing medical education courses; fitness center services, namely, providing fitness and exercise facilities

Charitable fundraising services in the field of medicine

Medical and scientific research, namely, conducting clinical trials for others; Translational research, namely, medical research involving the translation of findings in scientific research to medical practice; providing scientific analysis and scientific research consulting in the fields of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and to assess risks associated with certain diseases; consulting in the field of laboratory research to report on the results of laboratory testing in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases; medical laboratory services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 1, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 12, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 12, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 14, 2026 SUPC
USE AMENDMENT FILED
May 6, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
May 6, 2026 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 20, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2026 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 20, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2025 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 22, 2025 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2025 CRFA
ASSIGNED TO LIE
Oct 22, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 13, 2025 ERSI
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 10, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 10, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 10, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 10, 2025 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 17, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 16, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 27, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 27, 2024 GNSL
SUSPENSION LETTER WRITTEN
Feb 27, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2023 NWOS
NEW APPLICATION ENTERED
May 26, 2023 NWAP